Manejo preoperatorio de la anemia en cirugia oncologica.

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Molins-Espinosa J

Grups d'Investigació

Abstract

Preoperative anemia in patients with cancer is highly prevalent, is associated with increased perioperative morbidity and is a risk factor for transfusion. There is evidence that patients who undergo transfusions have higher morbidity, increased cancer recurrence and poorer survival. The pathophysiology of anemia is multifactorial, with an inflammatory component to which chronic blood loss and nutritional deficiencies can be associated. Therefore, preoperative anemia in patients with cancer should be treated appropriately, given that there is sufficient time in the preoperative period. Of the currently available options, parenteral iron is an effective alternative, especially for those types of cancer that have an associated hemorrhagic component.

Dades de la publicació

ISSN/ISSNe:
0034-9356, 2340-3284

Revista espanola de anestesiologia y reanimacion  ELSEVIER SCIENCE BV

Tipus:
Article
Pàgines:
45-51
PubMed:
26320344
Factor d'Impacte:
0,205 SCImago
Quartil:
Q3 SCImago

Cites Rebudes en Web of Science: 1

Documents

  • No hi ha documents

Mètriques

Filiacions

Filiacions no disponibles

Keywords

  • *Anemia preoperatoria; *Cirugia oncologica; *Hierro parenteral; *Oncologic surgery; *Parenteral iron; *Preoperative anemia; *Transfusion; *Transfusion

Compartir la publicació